Obesity Clinical Trial
Official title:
A Randomised Controlled Comparison of Effectiveness of Facemask Preoxygenation and Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) in Bariatric Patients Undergoing General Anaesthesia
The purpose of the study is to compare effectiveness of different methods of achieving
pre-oxygenation in bariatric patients. The investigators intend to compare facemask
pre-oxygenation with a high-flow humidified nasal oxygen.
The primary outcome measure of interest is time to desaturation to 92% or 18 minutes of
apnoea.
General anaesthesia involves giving patients anaesthetic and muscle relaxant medications to
allow transition to sleep and airway relaxation to permit laryngoscopy, respectively. During
laryngoscopy, a breathing tube is placed to 'secure' the airway. There is therefore a length
of time from administration of these medications to when the breathing tube is placed, when
the patient is not breathing and the airway is not secured. This time is known as apnoea
time. In a patient who is not breathing, blood oxygen levels fall to dangerously-low levels,
within 1-2 minutes. In order to prevent this, patients breathe 100% oxygen before induction
of anaesthesia as part of a process known as pre-oxygenation. There are different ways of
delivering pre-oxygenation, but the common aim is to increase the oxygen reservoir within the
lungs to give the anaesthetist more time to place the breathing tube. With good
pre-oxygenation, apnoea times of up to 7 minutes are possible.
Apnoea time is a potentially hazardous period during induction of anaesthesia and it is
particularly so in patients with severe obesity. On the one hand, obesity makes the upper
airway anatomy difficult, and on the other hand, lung collapse (atelectasis) caused by
abdominal contents compressing the base of the lungs reduces the amount of oxygen available
within the lungs. Apnoea time can be as short of 30 seconds. Identifying the most effective
method of pre-oxygenating bariatric patients can therefore significantly improve the safety
of delivering general anaesthesia to these patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |